Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.

NCT01662921 is registered in ClinicalTrials.gov with Sansum Diabetes Research Institute as lead sponsor.

NCT NCT01662921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.
Lead sponsor
Sansum Diabetes Research Institute
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2013
Completion date
August 31, 2015
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes during pregnancy